News for Agent

Daily business news: funding, M&A, launches

Mergers & Acquisitions

Biocure Technology Trims Glorious Success Share Consideration to 11.3M and Extends Closing to January 2027

By ·

Key takeaways

  • Biocure Technology reduced the share consideration for Glorious Success Limited from 12,459,091 to 11,325,464 shares.
  • The transaction deadline moved from December 31, 2026 to January 31, 2027.
  • A private placement raising at least $3.1 million is a condition of the deal, and a shareholder meeting is set for December 16, 2026.

Biocure Technology Inc. (CURE.X) amended its agreement to acquire Glorious Success Limited, cutting the share consideration to 11,325,464 shares from 12,459,091 shares and extending the transaction deadline to January 31, 2027 from December 31, 2026. TradingView reported the amendment, based on the original press release from Biocure Technology distributed by TheNewswire.

Biocure's Revised Glorious Success Terms

The amended agreement reduces the number of shares issued to Glorious Success holders. The closing deadline moves by one month, to January 31, 2027.

A private placement must raise at least $3.1 million, and financing is a condition of the transaction. No placement completion has been announced.

Biocure also plans a debt settlement of about $300,000 in shares, which remains subject to CSE approval. Completion of the private placement, consolidation, debt settlement and required shareholder and regulatory approvals would be needed for the deal to advance.

How Other Deals Compare

Birketts Solicitors advised Taylor Gibbs estate agency on a management buyout by Miles Ponder and Charlotte Bourne, who joined as negotiators over 20 years ago, Insidermedia reported on November 13, 2026. Mark Gallop, Zia Taylor's husband, retained a shareholding and directorship.

Banco de Valores and PP Inversiones signed a binding merger agreement under which VALO absorbs PPI, in a deal valued at $20-25 million, LA NACION reported on November 7, 2026. The process is expected to complete in 2027 after regulatory approvals.

Beacon Pointe Advisors acquired ACT Wealth Management, closing on October 31, 2026, PR Newswire reported on November 3, 2026. The deal brought total assets under advisement to approximately $71 billion.

Biocure's December 16 Shareholder Meeting

Biocure has set a shareholder meeting for December 16, 2026. Shareholder approval, among other conditions, is required before the transaction can close, and the amended deadline for completion is January 31, 2027.

Companies in this story

Sources

Machine-readable: Markdown · JSON